Disorders of iron metabolism I. Regulation of iron homeostasis

Česká verzia

Authors: J. Novotný
Authors place of work: Oddělení klinické hematologie FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Miroslav Penka, CSc., Transfuzní oddělení a krevní banka FN Brno, pracoviště Bohunice, přednosta prim. MUDr. Eva Tesařová
Published in the journal: Vnitř Lék 2005; 51(6): 681-689
Category: Original Contributions

Summary

Iron is an ubiquitously ocurring vital element which can be found in all living cell from bacterias and yeasts to mammals. The cells explore the redox potential of iron, which can be used in many essential and vital biochemical reactions. The iron homeostasis must be very finely tuned beacuse iron overload may lead to the generation of very toxic reactive oxid radicals, which may damage lipids, proteins and nucleic acids with possible severe cellular damage and death. Iron homeostasis is maintained on cellular and whole body levels and details of this fascinating network have been disclosed only very recently. The transferrin receptor (TfR) and ferritin play the main roles on cellular level of iron homeostasis maintaining. The expression of these proteins are under tight control of iron regulatory proteins (IRPs), which bind to specific parts of mRNA molecules, called iron regulatory elements (IREs). If the IRE is localized in 5’UTR (untranslated region) of mRNA molecule, the binding of IRP blocks translation of this mRNA. In case when the IRE lays in the 3’UTR, the binding of IRP stabilizes the mRNA and potentiates its translation. Excess of cellular iron causes high expression of ferritin genes and blocks the expression of TfR gene, in case of sideropenia the processes are reverse. The absorption and transport of iron to the blood by enterocytes and the retention or release of iron by macrophages represent the main regulatory processes of iron homeostasis on the whole body level. The enterocytes regulate the input of iron to the body by increasing or decreasing its absorption from the enteral lumen and its transport across the basolateral membrane to the blood. According to so called „preprogramming theory“ is the precursor cell of the enteral crypts preprogrammed by the body iron status to increased or decreased absorption and transport of iron. HFE protein, discovered by Feder et al. in 1996, plays very important role in these regulations. The C282Y mutation of HFE protein is the main cause of hereditary iron overload in causasoid populations worldwide as its homozygote status can be detected in more than 80 % of causasoid patients with hereditary hemochromatosis.

Key words:
iron – sideropenia – iron overload – hereditary hemochromatosis

Zdroje

1. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000; 275: 19906–19912.

2. Conrad ME, Umbreit JN. A concise review: iron absorption: the mucin-mobilferin- integrin pathway: a competitive pathway for metal absorption. Am J Hematol 1993; 42: 67–73.

3. Dupic F, Fruchon S, Bensaid M et al. Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains. Gastroenterology 2002; 122: 745–751.

4. Eisenstein RS. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000; 20: 627–662.

5. Feder JN, Penny DM, Irrinki A et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998; 95: 1472–1477.

6. Feder JN, Tusuchihashi Z, Irrinki A et al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272: 14025–14028.

7. Fleming RE, Sly WS. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. J Clin Invest 2001; 108: 521–522.

8. Goswami T, Rolfs A, Hedinger MA. Iron transport: emerging roles in health and disease. Biochem Cell Biol 2002; 80: 679–689.

9. Guo B, Phillips JD, Yu Y et al. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J Biol Chem 1995; 270: 21645–21651.

10. Hallberg L, Rossander L. Absorption of iron from Western lunch and dinner meals. Am J Clin Nutr 1982; 35: 502–509.

11. Harrison SA, Bacon BR. Hereditary hemochromatosis: update for 2003. J Hepatol 2003; 38(Suppl 1): S14–S23.

12. Hirling H, Henderson BR, Kuhn LC. Mutational analysis of the (4Fe–4S)–cluster converting iron regulatory factor from its RNA binding form to cytoplasmic aconitase. EMBO J 1994; 13: 453–461.

13. Ikuta K, Fujimoto Y, Suzuki Y. et al. Overexpression of HFE alters transferrin recycling process in human hepatoma cells. Biochim Biophys Acta 2000; 1496: 221–231.

14. Klausner RD, Rouault TA, Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993; 72: 19–28.

15. Lee GR, Herbert V. Nutritional factors in the production and function of erythrocytes. In: Wintrobe’s Clinical Hematology. 10^th ed. Philadelphia: Lippincott, Williams and Wilkins 1999: 228–266.

16. Levy JE, Montross LK, Cohen DE et al. The C282Ymutation causing hereditary hemochromatosis does not produce a null allele. Blood 1999; 94: 9–11.

17. Montosi G, Donovan A, Totaro A et al. Autosomal dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001; 108: 619–623.

18. Muckenthaler M, Roy CN, Custodio AO et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hermochromatosis. Nature Genetics 2003; 34: 102–107.

19. Nicolas G, Viatte L, Lou DQ et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nature Genetics 2003; 34: 97–101.

20. Pantopoulos K, Weiss G, Hentze M. Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways. Mol Cell Biol 1996; 16: 3781–3788.

21. Recalcati S, Taramelli D, Conte D et al. Nitric oxide–mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood 1998; 91: 1059–1066.

22. Roetto A, Merryweather–Clarke AT, Daraio F et al. A valine deletion of ferroportin 1: a common mutation in hemochromatosis type 4. Blood 2002; 100: 733–734.

23. Rolfs A, Bonkovsky HL, Kohlroser JG et al. Intestinal expression of genes involved in iron absorption in humans. Am J Physiol 2002; 282: G598–G607.

24. Rothenberg BE, Voland JR. Β2m knockout mice develop parenchymal iron overload: a putative role of

class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 1996; 93: 1529–1534.

25. Roy CN, Enns CA. Iron homeostasis: new tales from the crypt. Blood 2000; 96: 4020–4027.

26. Samamiengo F, Chin J, Uwai K et al. Molecular characterization of a second iron responsive element binding protein, iron regulatory protein 2. J Biol Chem 1994; 269: 30904–30910.

27. Trinder D, Macey DJ, Olynyk JK. The new iron age (review). Int J Molec Med 2000; 6: 607–612.

28. Trinder D, Olynyk JK, Sly WS et al. Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse. Proc Natl Acad Sci USA 2002; 99: 5622–5626.

29. Waheed A, Grubb JH, Zhou XY et al. Regulation of transferrin-mediated iron uptake by HFE, the protein

defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 2002; 99: 3117–3122.

30. Weiss G, Goossen B, Doppler W et al. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J 1993; 12: 3651–3657.

31. Zhou XY, Tomatsu S, Fleming RL et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492–2497.